Back to resultsPhase 4 Study Comparing IOP Lowering in OAG or OH in Caucasian or Japanese Subjects C-02-32
Primary Purpose
Open-angle Glaucoma, Ocular Hypertension
Status
Terminated
Phase
Phase 4
Locations
Study Type
Interventional
Intervention
IOP Lowering Medications
Sponsored by
About this trial
This is an interventional treatment trial for Open-angle Glaucoma focused on measuring open-angle, glaucoma, ocular, hypertension, POAG, Iris, Pigmentation, Japanese
Eligibility Criteria
Adults of Caucasian and Japanese Ethnicity
Sites / Locations
Outcomes
Primary Outcome Measures
Secondary Outcome Measures
Full Information
1. Study Identification
Unique Protocol Identification Number
NCT00047606
Brief Title
Phase 4 Study Comparing IOP Lowering in OAG or OH in Caucasian or Japanese Subjects C-02-32
Official Title
Phase 4 Study to Compare Two Different IOP Lowering Medications for the Treatment of Open Angle Glaucoma or Ocular Hypertension in Caucasian and Japanese Subjects C-02-32.
Study Type
Interventional
2. Study Status
Record Verification Date
August 2008
Overall Recruitment Status
Terminated
Why Stopped
Management Decision
Study Start Date
August 2002 (undefined)
Primary Completion Date
November 2003 (Actual)
Study Completion Date
November 2003 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Alcon Research
4. Oversight
5. Study Description
Brief Summary
The purpose of this study is to evaluate safety and efficacy of two different IOP lowering medications after six weeks of treatment in Caucasian and Japanese subjects.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Open-angle Glaucoma, Ocular Hypertension
Keywords
open-angle, glaucoma, ocular, hypertension, POAG, Iris, Pigmentation, Japanese
7. Study Design
Primary Purpose
Treatment
Study Phase
Phase 4
Interventional Study Model
Parallel Assignment
Masking
Double
Allocation
Randomized
Enrollment
84 (Actual)
8. Arms, Groups, and Interventions
Intervention Type
Drug
Intervention Name(s)
IOP Lowering Medications
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Adults of Caucasian and Japanese Ethnicity
12. IPD Sharing Statement
Learn more about this trial
Phase 4 Study Comparing IOP Lowering in OAG or OH in Caucasian or Japanese Subjects C-02-32
We'll reach out to this number within 24 hrs